Data at Heart Rhythm 2026 highlight key Boston Scientific therapies

Positive data for FARAPULSE™ Pulsed Field Ablation and WATCHMAN™ LAAC Devices underscore therapy safety and effectiveness in late-breaking clinical trial sessions MARLBOROUGH, Mass. and CHICAGO, April 26, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced data...